Browse by Basel Contributors ID
2017Sanderson, Nicholas S. R. and Zimmermann, Maria and Eilinger, Luca and Gubser, Céline and Schaeren-Wiemers, Nicole and Lindberg, Raija L. P. and Dougan, Stephanie K. and Ploegh, Hidde L. and Kappos, Ludwig and Derfuss, Tobias. (2017) Cocapture of cognate and bystander antigens can activate autoreactive B cells. Proceedings of the National Academy of Sciences of the United States of America, 114 (4). pp. 734-739. 2016Rasenack, M. and Rychen, J. and Andelova, M. and Naegelin, Y. and Stippich, C. and Kappos, L. and Lindberg, R. L. and Sprenger, T. and Derfuss, T.. (2016) Efficacy and Safety of Fingolimod in an Unselected Patient Population. PLoS One, 11 (1). e0146190. Meira, Maria and Sievers, Claudia and Hoffmann, Francine and Haghikia, Aiden and Rasenack, Maria and Decard, Bernhard F. and Kuhle, Jens and Derfuss, Tobias and Kappos, Ludwig and Lindberg, Raija L.P.. (2016) Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development. Neurol Neuroimmunol Neuroinflamm, 3 (3). e223. Hegen, Harald and Adrianto, Indra and Lessard, Christopher J. and Millonig, Alban and Bertolotto, Antonio and Comabella, Manuel and Giovannoni, Gavin and Guger, Michael and Hoelzl, Martina and Khalil, Michael and Fazekas, Franz and Killestein, Joep and Lindberg, Raija L.P. and Malucchi, Simona and Mehling, Matthias and Montalban, Xavier and Rudzki, Dagmar and Schautzer, Franz and Sellebjerg, Finn and Sorensen, Per Soelberg and Deisenhammer, Florian and Steinman, Lawrence and Axtell, Robert C.. (2016) Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients. Neurol Neuroimmunol Neuroinflamm, 3 (2). e202. 2015UNSPECIFIED. (2015) Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Journal of neuroinflammation, Vol. 12. p. 46. Matsushita, T. and Madireddy, L. and Sprenger, T. and Khankhanian, P. and Magon, S. and Naegelin, Y. and Caverzasi, E. and Lindberg, R. L. and Kappos, L. and Hauser, S. L. and Oksenberg, J. R. and Henry, R. and Pelletier, D. and Baranzini, S. E.. (2015) Genetic associations with brain cortical thickness in multiple sclerosis. Genes, Brain and Behavior, 14 (2). pp. 217-227. 2014Hegen, H. and Millonig, A. and Bertolotto, A. and Comabella, M. and Giovanonni, G. and Guger, M. and Hoelzl, M. and Khalil, M. and Killestein, J. and Lindberg, R. and Malucchi, S. and Mehling, M. and Montalban, X. and Polman, C. and Rudzki, D. and Schautzer, F. and Sellebjerg, F. and Sorensen, P. and Deisenhammer, F.. (2014) Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Multiple sclerosis, Vol. 20, H. 5. pp. 577-587. Meira, Meira and Sievers, Claudia and Hoffmann, Francine and Rasenack, Maria and Kuhle, Jens and Derfuss, Tobias and Kappos, Ludwig and Lindberg, Raija L. P.. (2014) Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. Journal of Immunology Research, 2014. p. 897249. Meira, Maria and Sievers, Claudia and Hoffmann, Francine and Derfuss, Tobias and Kuhle, Jens and Kappos, Ludwig and Lindberg, Raija L. P.. (2014) MiR-126: a novel route for natalizumab action? Multiple Sclerosis Journal, 20 (10). pp. 1363-1370. 2013Ricklin, M. E. and Lorscheider, J. and Waschbisch, A. and Paroz, C. and Mehta, S. K. and Pierson, D. L. and Kuhle, J. and Fischer-Barnicol, B. and Sprenger, T. and Lindberg, R. L. and Kappos, L. and Derfuss, T.. (2013) T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology, Vol. 81, H. 2. pp. 174-181. Gaiottino, J. and Norgren, N. and Dobson, R. and Topping, J. and Nissim, A. and Malaspina, A. and Bestwick, J. P. and Monsch, A. U. and Regeniter, A. and Lindberg, R. L. and Kappos, L. and Leppert, D. and Petzold, A. and Giovannoni, G. and Kuhle, J.. (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE, Vol. 8, H. 9 , e75091. Derfuss, T. and Kuhle, J. and Lindberg, R. and Kappos, L.. (2013) Natalizumab therapy for multiple sclerosis. Seminars in neurology, Vol. 33, H. 1. pp. 26-36. Kuhle, J. and Plattner, K. and Bestwick, J. P. and Lindberg, R. L. and Ramagopalan, S. V. and Norgren, N. and Nissim, A. and Malaspina, A. and Leppert, D. and Giovannoni, G. and Kappos, L.. (2013) A comparative study of CSF neurofilament light and heavy chain protein in MS. Multiple Sclerosis Journal, 19 (12). pp. 1597-1603. Mehling, M. and Fritz, S. and Hafner, P. and Eichin, D. and Yonekawa, T. and Klimkait, T. and Lindberg, R. L. and Kappos, L. and Hess, C.. (2013) Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNbeta-Therapy. PLoS ONE, Vol. 8, H. 11 , e78532. 2012Rejdak, K. and Kuhle, J. and Ruegg, S. and Lindberg, R. L. and Petzold, A. and Sulejczak, D. and Papuc, E. and Rejdak, R. and Stelmasiak, Z. and Grieb, P.. (2012) Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury. Epilepsia, Vol. 53, H. 5. pp. 922-927. Sievers, C. and Meira, M. and Hoffmann, F. and Fontoura, P. and Kappos, L. and Lindberg, R. L.. (2012) Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clinical immunology, Vol. 144, H. 1. pp. 70-79. Gensicke, H. and Leppert, D. and Yaldizli, O. and Lindberg, R. L. and Mehling, M. and Kappos, L. and Kuhle, J.. (2012) Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis. CNS Drugs, 26 (1). pp. 11-37. 2011Kuhle, J. and Leppert, D. and Petzold, A. and Regeniter, A. and Schindler, C. and Mehling, M. and Anthony, D. C. and Kappos, L. and Lindberg, R. L.. (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology, Vol. 76, H. 14. pp. 1206-1213. Mehling, M. and Hilbert, P. and Fritz, S. and Durovic, B. and Eichin, D. and Gasser, O. and Kuhle, J. and Klimkait, T. and Lindberg, R. L. P. and Kappos, L. and Hess, C.. (2011) Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Annals of neurology, Vol. 69, H. 2. pp. 408-413. 2010Mehling, M. and Lindberg, R. and Raulf, F. and Kuhle, J. and Hess, C. and Kappos, L. and Brinkmann, V.. (2010) Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology, Vol. 75, H. 5. pp. 403-410. Kuhle, Jens and Regeniter, Axel and Leppert, David and Mehling, Matthias and Kappos, Ludwig and Lindberg, Raija L. P. and Petzold, Axel. (2010) A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. Journal of neuroimmunology, Vol. 220, H. 1/2. pp. 114-119. Gilli, Francesca and Lindberg, Raija L. P. and Valentino, Paola and Marnetto, Fabiana and Malucchi, Simona and Sala, Arianna and Capobianco, Marco and di Sapio, Alessia and Sperli, Francesca and Kappos, Ludwig and Calogero, Raffaele A. and Bertolotto, Antonio. (2010) Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS ONE, Vol. 5 , e8962. Lindberg, Raija L. P. and Hoffmann, Francine and Mehling, Matthias and Kuhle, Jens and Kappos, Ludwig. (2010) Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. European journal of immunology, Vol. 40, H. 3. pp. 888-898. Ströbel, Simon and Loparic, Marko and Wendt, David and Schenk, Andreas D. and Candrian, Christian and Lindberg, Raija L. P. and Moldovan, Florina and Barbero, Andrea and Martin, Ivan. (2010) Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages. Arthritis research & therapy, Vol. 12 , R34. 2009Kuhle, J. and Lindberg, R. L. P. and Regeniter, A. and Mehling, M. and Steck, A. J. and Kappos, L. and Czaplinski, A.. (2009) Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European journal of neurology, Vol. 16. pp. 771-774. Baranzini, Sergio E. and Galwey, Nicholas W. and Wang, Joanne and Khankhanian, Pouya and Lindberg, Raija and Pelletier, Daniel and Wu, Wen and Uitdehaag, Bernard M. J. and Kappos, Ludwig and Polman, Chris H. and Matthews, Paul M. and Hauser, Stephen L. and Gibson, Rachel A. and Oksenberg, Jorge R. and Barnes, Michael R.. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human molecular genetics, Vol. 18. pp. 2078-2090. Baranzini, S. E. and Wang, J. and Gibson, R. A. and Galwey, N. and Naegelin, Y. and Barkhof, F. and Radue, E. W. and Lindberg, R. L. and Uitdehaag, B. M. and Johnson, M. R. and Angelakopoulou, A. and Hall, L. and Richardson, J. C. and Prinjha, R. K. and Gass, A. and Geurts, J. J. and Kragt, J. and Sombekke, M. and Vrenken, H. and Qualley, P. and Lincoln, R. R. and Gomez, R. and Caillier, S. J. and George, M. F. and Mousavi, H. and Guerrero, R. and Okuda, D. T. and Cree, B. A. and Green, A. J. and Waubant, E. and Goodin, D. S. and Pelletier, D. and Matthews, P. M. and Hauser, S. L. and Kappos, L. and Polman, C. H. and Oksenberg, J. R.. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human molecular genetics, Vol. 18. pp. 767-778. 2008Lindberg, R. L. and Achtnichts, L. and Hoffmann, F. and Kuhle, J. and Kappos, L.. (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. Journal of neuroimmunology, Vol. 194. pp. 153-164. Mehling, M. and Brinkmann, V. and Antel, J. and Bar-Or, A. and Goebels, N. and Vedrine, C. and Kristofic, C. and Kuhle, J. and Lindberg, R. L. and Kappos, L.. (2008) FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology, Vol. 71, H. 16. pp. 1261-1267. Ishihara, Hideyuki and Kubota, Hisashi and Lindberg, Raija L. P. and Leppert, David and Gloor, Sergio M. and Errede, Mariella and Virgintino, Daniela and Fontana, Adriano and Yonekawa, Yasuhiro and Frei, Karl. (2008) Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins. Journal of neuropathology and experimental neurology, Vol. 67, H. 5. pp. 435-448. Farrell, R. and Bendtzen, K. and Bertolotto, A. and Clark, B. and Comabella, M. and Deisenhammer, F. and Fogdell-Hahn, A. and Giovannoni, G. and Hartung, H. P. and Hemmer, B. and Hillert, J. and Kappos, L. and Killestein, J. and Lindberg, R. and Montalban, X. and Polman, C. and Sorensen, P. S. and European, Nabinms Consortium. (2008) Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis. Journal of international medical research, Vol. 36, H. 1 , S. 204-208 ; author reply 208-210. |
